Cargando…
EGFR-AS1 Promotes Nonsmall Cell Lung Cancer (NSCLC) Progression via Downregulating the miR-524-5p/DRAM1 Axis and Inhibiting Autophagic Lysosomal Degradation
Nonsmall cell lung cancer (NSCLC) accounts for the majority of lung cancers. Studies have revealed the regulatory role of lncRNAs in cancer pathogenesis and their potential use as diagnostic and prognostic biomarkers. The epidermal growth factor receptor antisense RNA 1 (EGFR-AS1) has been reported...
Autores principales: | Xue, Yang, Zhang, Jing, Hou, Jiguang, Wang, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866007/ https://www.ncbi.nlm.nih.gov/pubmed/35222643 http://dx.doi.org/10.1155/2022/4402536 |
Ejemplares similares
-
DRAM1 plays a tumor suppressor role in NSCLC cells by promoting lysosomal degradation of EGFR
por: Geng, Ji, et al.
Publicado: (2020) -
DRAM1 Regulates Autophagy Flux through Lysosomes
por: Zhang, Xing-Ding, et al.
Publicado: (2013) -
DRAM1 Promotes Lysosomal Delivery of Mycobacterium marinum in Macrophages
por: Banducci-Karp, Adrianna, et al.
Publicado: (2023) -
DRAM is Involved in Hypoxia/Ischemia-Induced Autophagic Apoptosis in Hepatocytes
por: Xu, Jianji, et al.
Publicado: (2019) -
Triamterene induces autophagic degradation of lysosome by exacerbating lysosomal integrity
por: Park, Na Yeon, et al.
Publicado: (2021)